Tag: Théa Pharma
Press Release: Théa to Acquire Branded Ophthalmic Products from Akorn, Expanding...
The purchase will add seven established brands, including Akorn’s leading glaucoma therapy, Zioptan®, to Théa’s portfolio. Théa will also welcome Akorn’s nearly 50-person sales force, which Théa expects to expand in support of anticipated growth and launches of additional products in the U.S.